Amyloid-beta immunotherapy: the hope for Alzheimer disease?
Colomb. med; 47 (4), 2016
Abstract Alzheimer disease (AD) is the most prevalent form of dementia of adult-onset, characterized by progressive impairment in cognition and memory. There is no cure for the disease and the current treatments are only symptomatic. Drug discovery is an expensive and time-consuming process; in the last ...
Enfermedad de Alzheimer/terapia, Péptidos beta-Amiloides/inmunología, Inmunoterapia/Métodos, Enfermedad de Alzheimer/inmunología, Enfermedad de Alzheimer/fisiopatología, Anticuerpos Monoclonales/farmacología, Anticuerpos Monoclonales/uso terapéutico, Progresión de la Enfermedad, Péptidos/farmacología, Péptidos/uso terapéutico